• Sobi receives SFDA approval for Orfadin capsules pharmaceutical-technology
    May 27, 2017
    Specialist healthcare company Swedish Orphan Biovitrum (Sobi) has received approval from the Saudi Food and Drug Administration (SFDA) for Orfadin (nitisinone) capsules in strengths of 2mg, 5mg, 10mg and 20mg.
PharmaSources Customer Service